Evolva brings natural sugar blocker to market The biotech company Evolva is introducing L-arabinose to the market. This product is a natural sugar blocker and can be…martin01.21.2021
Holmusk opens new office in Basel Holmusk has opened an office in Basel. The company from Singapore develops digital therapies on the basis of data analysis.…martin01.18.2021
Zifo RnD Solutions coming to Basel Zifo RnD Solutions, a global provider of IT solutions for research-based organizations, opens its latest subsidiary in Basel. With Zifo…martin01.04.2021
«We will show the new product at the Olympic Games 2021 in Tokyo» The new Basel Area Business & Innovation Podcast offers exciting conversations with interesting interview partners. The first guest is surgeon…martin12.15.2020
Patients stand to benefit from innovative tech project The investment and innovation promotion agency Basel Area Business & Innovation is joining forces with several partners to realize a…martin12.11.2020
Boehringer Ingelheim acquires Basel’s NBE-Therapeutics German pharma group Boehringer Ingelheim is to acquire the Basel life sciences company NBE-Therapeutics for €1.18 billion. NBE-Therapeutics specializes in…martin12.10.2020
Noema Pharma raises 54 million Swiss francs The Basel-based pharmaceutical company Noema Pharma has raised a total of 54 million Swiss francs as part of a Series…martin12.01.2020
Meteoblue constantly presents new developments The meteoblue weather service based in Basel has developed a weather map widget that can be embedded in any website.…martin11.26.2020
Lonza manufactures coronavirus vaccine for Moderna Lonza plans to start production of Moderna’s coronavirus vaccine in Switzerland before the end of the year. Moderna published the…martin11.17.2020
Synendos raises 20 million Swiss francs Synendos Therapeutics has concluded a Series A financing round, raising 20 million Swiss francs. The Basel biotech will use the…martin11.12.2020